L64.0Drug-induced androgenic alopecia

L64.0 is the ICD-10-CM diagnosis code for drug-induced androgenic alopecia. It belongs to category L64 (androgenic alopecia), block L60-L75 (disorders of skin appendages) and chapter 12 (diseases of the skin and subcutaneous tissue). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within L64 (androgenic alopecia), L64.0 is specifically for drug-induced androgenic alopecia. Related codes cover other androgenic alopecia (L64.8) and unspecified (L64.9).

Use an additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 606 (Minor Skin Disorders with MCC, relative weight 1.5728) and DRG 607 (Minor Skin Disorders without MCC, relative weight 0.8772), in MDC 09 (Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 704.09 (other alopecia).